T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME
US Application 63/503,578
Filed on 2023-05-22
Filed on 2023-05-22
TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA
US Application 63/216,777
Filed on 2021-06-30
Filed on 2021-06-30
A MOLECULAR SCAFFOLD FOR DEPLETING HRPN13 AND A SELECT GROUP OF KEN BOX PROTEINS
US Application 63/539,663
Filed on 2023-09-21
Filed on 2023-09-21
Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis
US Application 63/262,788
Filed on 2021-10-20
Filed on 2021-10-20
DEVELOPMENT OF NOVEL ANTIBODIES AND SINGLE CHAIN VARIABLE FRAGMENTS AGAINST EXTRACELLULAR PRAME
US Application 63/530,440
Filed on 2023-08-02
Filed on 2023-08-02
HUMANIZED 40H3 ANTIBODY
US Application 63/525,493
Filed on 2023-07-07
Filed on 2023-07-07
Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer
US Application 63/469,641
Filed on 2023-05-30
Filed on 2023-05-30
Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US Application 62/901,638
Filed on 2019-09-17
Filed on 2019-09-17
Fully Human Chimeric Antigen Receptors against CD276 for the treatment of solid tumors
US Application 63/514,596
Filed on 2023-07-20
Filed on 2023-07-20
SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF
US Application 63/501,772
Filed on 2023-05-12
Filed on 2023-05-12